Identification of protoberberine alkaloids as novel histone methyltransferase G9a inhibitors by structure-based virtual screening

[1]  Cheng Luo,et al.  Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines. , 2016, European journal of medicinal chemistry.

[2]  R. Cummings,et al.  S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3 , 2016, Proceedings of the National Academy of Sciences.

[3]  Hualiang Jiang,et al.  Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening. , 2015, Journal of medicinal chemistry.

[4]  Hualiang Jiang,et al.  Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1). , 2014, Organic & biomolecular chemistry.

[5]  Hualiang Jiang,et al.  Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening. , 2014, Journal of medicinal chemistry.

[6]  Y. H. Kim,et al.  Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome. , 2014, Bioorganic & medicinal chemistry.

[7]  Q. Xia,et al.  Inhibition of H3K9 Methyltransferase G9a Repressed Cell Proliferation and Induced Autophagy in Neuroblastoma Cells , 2014, PloS one.

[8]  M. Hsiao,et al.  Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma , 2014, Molecular Cancer.

[9]  R. Quinn,et al.  Biologically active isoquinoline alkaloids with drug-like properties from the genus Corydalis , 2014 .

[10]  Dong Eun Kim,et al.  BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production , 2013, Autophagy.

[11]  J. Medina-Franco,et al.  Molecular modeling and virtual screening of DNA methyltransferase inhibitors. , 2013, Current pharmaceutical design.

[12]  Robert Brown,et al.  Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. , 2013, Nature chemical biology.

[13]  Hualiang Jiang,et al.  Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation. , 2012, Journal of medicinal chemistry.

[14]  Qiwei Yang,et al.  BIX‐01294 treatment blocks cell proliferation, migration and contractility in ovine foetal pulmonary arterial smooth muscle cells , 2012, Cell proliferation.

[15]  S. Schreiber,et al.  A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma , 2012, ACS chemical biology.

[16]  Theonie Anastassiadis,et al.  Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity , 2011, Nature biotechnology.

[17]  Peter A. DiMaggio,et al.  A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. , 2011, Nature chemical biology.

[18]  Chengjun Piao,et al.  New cytotoxic tetrahydroprotoberberine-aporphine dimeric and aporphine alkaloids from Corydalis turtschaninovii. , 2010, Planta medica.

[19]  T. Okamoto,et al.  Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294* , 2010, The Journal of Biological Chemistry.

[20]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[21]  D. Reinberg,et al.  TILRR, a Novel IL-1RI Co-receptor, Potentiates MyD88 Recruitment to Control Ras-dependent Amplification of NF-κB* , 2009, The Journal of Biological Chemistry.

[22]  Valérie Campagna-Slater,et al.  Structural Biology of Human H3K9 Methyltransferases , 2010, PloS one.

[23]  Paul Greengard,et al.  Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity , 2010, Science.

[24]  Anton Simeonov,et al.  Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. , 2009, Journal of medicinal chemistry.

[25]  P. Greengard,et al.  Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex , 2009, Neuron.

[26]  Wolfgang Sippl,et al.  The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors , 2009, ChemMedChem.

[27]  Robert A. Copeland,et al.  Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.

[28]  S. Jacobsen,et al.  UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells , 2008, Nucleic acids research.

[29]  W. Sippl,et al.  Cancer treatment of the future: inhibitors of histone methyltransferases. , 2009, The international journal of biochemistry & cell biology.

[30]  A. Ishizaka,et al.  Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells , 2008, Cancer Cell International.

[31]  B. Ren,et al.  Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes , 2008, Journal of Biological Chemistry.

[32]  K. Bae,et al.  Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii. , 2008, Journal of ethnopharmacology.

[33]  Hideaki Kato,et al.  Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[34]  A. Lund,et al.  Chromatin‐modifying proteins in cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[35]  Karl Mechtler,et al.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. , 2007, Molecular cell.

[36]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[37]  Y. Shinkai,et al.  Zinc Finger Protein Wiz Links G9a/GLP Histone Methyltransferases to the Co-repressor Molecule CtBP* , 2006, Journal of Biological Chemistry.

[38]  Z. Duan,et al.  Gfi1 Coordinates Epigenetic Repression of p21Cip/WAF1 by Recruitment of Histone Lysine Methyltransferase G9a and Histone Deacetylase 1 , 2005, Molecular and Cellular Biology.

[39]  Axel Imhof,et al.  Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 , 2005, Nature chemical biology.

[40]  Tsutomu Ohta,et al.  Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. , 2005, Genes & development.

[41]  M. Walsh,et al.  CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[43]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[44]  Ajay N. Jain.  Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.

[45]  R. Clark,et al.  Consensus scoring for ligand/protein interactions. , 2002, Journal of molecular graphics & modelling.

[46]  Yoichi Shinkai,et al.  SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* , 2001, The Journal of Biological Chemistry.

[47]  C. Ponting,et al.  Regulation of chromatin structure by site-specific histone H3 methyltransferases , 2000, Nature.